{"id":7512,"date":"2026-02-28T13:54:11","date_gmt":"2026-02-28T13:54:11","guid":{"rendered":"https:\/\/dachtimes.com\/laccord-douanier-avec-les-etats-unis-force-les-geants-suisses-de-la-pharma-a-revoir-leur-strategie\/"},"modified":"2026-02-28T13:57:03","modified_gmt":"2026-02-28T13:57:03","slug":"laccord-douanier-avec-les-etats-unis-force-les-geants-suisses-de-la-pharma-a-revoir-leur-strategie","status":"publish","type":"post","link":"https:\/\/dachtimes.com\/fr\/laccord-douanier-avec-les-etats-unis-force-les-geants-suisses-de-la-pharma-a-revoir-leur-strategie\/","title":{"rendered":"L\u2019accord douanier avec les \u00c9tats-Unis force les g\u00e9ants suisses de la pharma \u00e0 revoir leur strat\u00e9gie"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>    <img fetchpriority=\"high\" src=\"https:\/\/www.swissinfo.ch\/content\/wp-content\/uploads\/sites\/13\/2025\/11\/627260095_highres.jpg?ver=0e61dc4b\" width=\"1300\" height=\"867\" alt=\"B\u00e2timents de Roche\" loading=\"eager\" decoding=\"sync\" fetchpriority=\"high\"\/><\/p>\n<p>                    <span class=\"image__caption-text\"><br \/>\n                En 2024,  Roche a ouvert un nouveau centre de recherche \u00e0 B\u00e2le.             <\/span><br \/>\n                        <span class=\"image__copyright-info\"><br \/>\n            Keystone \/ Georgios Kefalas        <\/span><\/p>\n<p><h2 class=\"lead-text__content\">\n        Les entreprises pharmaceutiques helv\u00e9tiques pr\u00e9voient d\u2019investir massivement dans la recherche et la production aux \u00c9tats-Unis dans le cadre d\u2019un accord visant \u00e0 obtenir une baisse des droits de douane. Mais de nombreux autres facteurs remettent en cause la&#8230;<\/h2>\n<\/p>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.swissinfo.ch\/fre\/innovation-en-sante\/us-trade-deal-forces-reckoning-for-swiss-pharma-powerhouse\/90460226\" target=\"_blank\" rel=\"noopener\">Fonte <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En 2024, Roche a ouvert un nouveau centre de recherche \u00e0 B\u00e2le. Keystone \/ Georgios Kefalas Les entreprises pharmaceutiques helv\u00e9tiques pr\u00e9voient d\u2019investir massivement dans la recherche et la production aux \u00c9tats-Unis dans le cadre d\u2019un accord visant \u00e0 obtenir une baisse des droits de douane. Mais de nombreux autres facteurs remettent en cause la&#8230; Fonte<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2028],"tags":[],"class_list":{"0":"post-7512","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-produits-pharmaceutiques-suisse"},"_links":{"self":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/posts\/7512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/comments?post=7512"}],"version-history":[{"count":1,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/posts\/7512\/revisions"}],"predecessor-version":[{"id":7538,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/posts\/7512\/revisions\/7538"}],"wp:attachment":[{"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/media?parent=7512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/categories?post=7512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dachtimes.com\/fr\/wp-json\/wp\/v2\/tags?post=7512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}